Comparison of efficacy of post-TURBT adjuvant intravesical mitomycin C therapy in preventing the recurrence of intermediate risk superficial TCC: peri-operative single dose versus delayed multi-dose regimen, short- versus long-term result
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.